resveratrol has been researched along with Memory Disorders in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (7.89) | 29.6817 |
| 2010's | 25 (65.79) | 24.3611 |
| 2020's | 10 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, ASC; Feng, X; Hu, J; Huang, L; Li, X; Wang, Z; Yang, X | 1 |
| An, L; Han, T; Jin, M; Liu, F; Song, B; Wang, Z; Zhang, L; Zhang, X | 1 |
| Tang, Z; Zhang, M | 1 |
| Dave, KR; Escobar, I; Fagerli, EA; Ferrier, FJ; Jackson, CW; López-Morales, MA; Perez-Pinzon, MA; Raval, AP; Saul, I | 1 |
| Calado, CMSDS; da Silva Souza, V; de Silveira, BS; de Souza, SL; Manhães-de-Castro, R; Pereira, SDC; Toscano, AE; Visco, DB | 1 |
| Farkhakfar, A; Hassanpour, S; Zendehdel, M | 1 |
| Chi, J; Gao, Y; Hu, J; Lv, W; Ma, X; Wang, W; Wang, Y; Xian, Y | 1 |
| Chen, N; He, C; He, X; Li, Y; Liu, Q; Liu, S; Xiao, P; Yi, F | 1 |
| Corpas, R; Gatius, A; Griñán-Ferré, C; Pallàs, M; Rodríguez-Farré, E; Sanfeliu, C; Sarroca, S; Vilchez, D | 1 |
| Alghamdi, BS; Alshehri, FS; Kurdi, M; Labban, S | 1 |
| Li, Y; Ru, Q; Shu, X; Tian, X; Xiong, Q; Yue, K; Zeng, Q; Zhou, M | 1 |
| Sang, W; Shen, D; Song, R; Tian, X | 1 |
| Cao, Y; Li, M; Li, MZ; Liu, BJ; Shi, FX; Sun, DS; Tian, Q; Wang, JZ; Wang, L; Xu, WQ; Zhou, XW | 1 |
| Chen, L; Fei, N; Huang, W; Li, G; Liu, N; Pan, J; Shi, J; Wang, G; Xie, X; Xu, Y; Yang, M | 1 |
| Dong, W; Ma, LN; Wang, R; Wang, YL; Xu, BL; Zhang, H; Zhang, JS; Zhang, X; Zhao, ZW | 1 |
| Arevalo-Garcia, R; Marti-Nicolovius, M | 1 |
| Liu, J; Meng, J; Qi, B; Shi, C; Xu, S | 1 |
| Ge, S; Wang, B; Xiong, W; Xue, Z | 1 |
| Chen, Y; Liang, ZM; Peng, L; Sheng, SY; Shi, GW; Shi, YS; Wang, F; Wang, YP; Zhang, XM | 1 |
| Bazi, A; Hashemzaei, M; Hosseindadi, F; Kordi, S; Musavi, SS; Rezaee, R; Rigi, M; Shahraki, J; Shamshirgaran, F; Tabrizian, K | 1 |
| Camins, A; Del Valle, J; Ferrer, I; Griñán-Ferré, C; Pallàs, M; Porquet, D; Sanfeliu, C | 1 |
| Aricioglu, F; Gacar, N; Utkan, T; Yazir, Y | 1 |
| Hattiangady, B; Kodali, M; Mishra, V; Parihar, VK; Shetty, AK; Shuai, B | 1 |
| Chen, FH; Chu, CH; Ge, JF; Li, N; Qin, G; Qiu, GL; Wang, CY; Xu, YY; Zhang, Y | 1 |
| Chen, L; Li, H; Rao, Y; Wang, J; Wang, P | 1 |
| Coleman, MA; Gavin, CF; Gilliam, D; Heyward, FD; Kaas, G; Lewis, J; Moulden, J; Sweatt, JD; Trieu, R; Wang, J | 1 |
| Abdel-Wahab, BA; Abdel-Wahab, MM | 1 |
| Chen, J; Chen, L; Cheng, R; Feng, X; O'Donnell, JM; Pan, X; Wang, G; Wang, L; Wang, W; Wu, F; Xu, Y; Yu, Y; Zhang, HT | 1 |
| Li, J; Wang, R; Zhang, C; Zhang, Y | 1 |
| Chen, YY; Shen, YL; Shi, DL; Song, XH; Wang, LL; Zhang, L; Zheng, MZ | 1 |
| Chitolina Schetinger, MR; Corrêa, M; da Rosa, MM; Gutierres, J; Mazzanti, CM; Morsch, VM; Rubin, MA; Schmatz, R; Spanevello, R; Stefanello, N | 1 |
| Gacar, N; Gocmez, SS; Komsuoglu Celikyurt, I; Mutlu, O; Ulak, G; Utkan, T | 1 |
| Cho, GJ; Choi, WS; Jeon, BT; Jeong, EA; Kang, SS; Kim, HJ; Lee, DH; Lee, Y; Roh, GS; Shin, HJ | 1 |
| Fan, N; Han, H; Li, X; Liu, T; Niu, Q; Tian, Q; Wang, W; Wang, Z; Xu, Y; Zhang, H; Zhao, H | 1 |
| Bhattacharya, SK; Gupta, LK; Gupta, R; Mediratta, PK | 1 |
| Battastini, AM; Bernardi, A; Frozza, RL; Guterres, SS; Hoppe, JB; Matté, A; Meneghetti, AB; Pohlmann, AR; Salbego, C | 1 |
| Kumar, A; Naidu, PS; Padi, SS; Seghal, N | 1 |
| Baykara, B; Erbil, G; Sönmez, A; Sönmez, U; Tekmen, I | 1 |
3 review(s) available for resveratrol and Memory Disorders
| Article | Year |
|---|---|
Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation.
Topics: Alzheimer Disease; Humans; Memory Disorders; Neurodegenerative Diseases; Resveratrol; Sirtuin 1 | 2023 |
Therapeutic advances for treating memory impairments in perinatal brain injuries with implications for cerebral palsy: a systematic review and meta-analysis of preclinical studies.
Topics: Brain Injuries; Cerebral Palsy; Erythropoietin; Hippocampus; Humans; Memory Disorders; Quality of Life; Resveratrol | 2023 |
[Caloric restriction and memory during aging].
Topics: Aged; Aged, 80 and over; Aging; Animals; Brain Chemistry; Caloric Restriction; Diet, Mediterranean; Female; Humans; Longevity; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Middle Aged; Models, Animal; Multicenter Studies as Topic; Rats; Rats, Inbred Strains; Resveratrol; Sirolimus | 2018 |
35 other study(ies) available for resveratrol and Memory Disorders
| Article | Year |
|---|---|
Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline-Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Cell Proliferation; Drug Design; Hippocampus; Humans; Indoles; Ligands; Memory Disorders; Mice; Quinolines | 2018 |
Resveratrol Ameliorates Trigeminal Neuralgia-Induced Cognitive Deficits by Regulating Neural Ultrastructural Remodelling and the CREB/BDNF Pathway in Rats.
Topics: Animals; Cognition; Cognitive Dysfunction; Elapid Venoms; Memory Disorders; Pain; Rats; Resveratrol; Trigeminal Neuralgia | 2022 |
Resveratrol Preconditioning Mitigates Ischemia-Induced Septal Cholinergic Cell Loss and Memory Impairments.
Topics: Animals; Brain Ischemia; Cell Death; Cognition; Infarction, Middle Cerebral Artery; Memory Disorders; Mice; Neuroprotective Agents; Rats; Resveratrol | 2023 |
Resveratrol plays neuroprotective role on ketamine-induced schizophrenia-like behaviors and oxidative damage in mice.
Topics: Animals; Disease Models, Animal; Ketamine; Male; Memory Disorders; Mice; Oxidative Stress; Resveratrol; Schizophrenia; Superoxide Dismutase | 2023 |
Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Inflammation; Memory Disorders; Mice; Mice, Inbred NOD; Resveratrol | 2020 |
Resveratrol oligomers from Paeonia suffruticosa protect mice against cognitive dysfunction by regulating cholinergic, antioxidant and anti-inflammatory pathways.
Topics: Acetylcholinesterase; Animals; Anti-Inflammatory Agents; Antioxidants; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognitive Dysfunction; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Paeonia; PC12 Cells; Plant Extracts; Rats; Resveratrol; Scopolamine | 2020 |
Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Brain; Cognitive Dysfunction; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Humans; Male; Memory Disorders; Mice; Mice, Transgenic; Neuroprotection; Neuroprotective Agents; Obesity; Proteasome Endopeptidase Complex; Proteolysis; Resveratrol; Ubiquitin | 2021 |
Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Behavior, Animal; Disease Models, Animal; Male; Melatonin; Memory Disorders; Mice; Neuroprotective Agents; Recognition, Psychology; Resveratrol | 2021 |
Resveratrol attenuates methamphetamine-induced memory impairment via inhibition of oxidative stress and apoptosis in mice.
Topics: Animals; Apoptosis; Kelch-Like ECH-Associated Protein 1; Memory Disorders; Methamphetamine; Mice; Molecular Docking Simulation; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol | 2021 |
Effect of Melatonin and Resveratrol against Memory Impairment and Hippocampal Damage in a Rat Model of Vascular Dementia.
Topics: Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Dementia, Vascular; Disease Models, Animal; Drug Therapy, Combination; Glutathione; Hippocampus; Interleukin-1beta; Male; Malondialdehyde; Maze Learning; Melatonin; Memory Disorders; Models, Molecular; Rats; Rats, Wistar; Recognition, Psychology; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2016 |
Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.
Topics: Adenylate Kinase; Aging; Alzheimer Disease; Aminoimidazole Carboxamide; Animals; Cannabinoids; Enzyme Activation; Gene Deletion; Glycogen Synthase Kinase 3 beta; Hippocampus; Memory; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Phosphorylation; Receptor, Cannabinoid, CB2; Resveratrol; Ribonucleotides; Signal Transduction; tau Proteins | 2018 |
trans-Resveratrol ameliorates anxiety-like behaviors and fear memory deficits in a rat model of post-traumatic stress disorder.
Topics: Adrenal Glands; Analysis of Variance; Animals; Antioxidants; Anxiety; Brain-Derived Neurotrophic Factor; Corticotropin-Releasing Hormone; CREB-Binding Protein; Disease Models, Animal; Exploratory Behavior; Fear; Male; Maze Learning; Memory Disorders; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Stress Disorders, Post-Traumatic | 2018 |
Resveratrol prevents high-calorie diet-induced learning and memory dysfunction in juvenile C57BL/6J mice.
Topics: Animals; Biomarkers; Body Weight; CA1 Region, Hippocampal; Diet, High-Fat; Female; Learning Disabilities; Male; Maze Learning; Memory; Memory Disorders; Mice, Inbred C57BL; Neuroprotection; Nootropic Agents; Random Allocation; Resveratrol; Sirtuin 1; Stilbenes | 2018 |
Resveratrol alleviates ethanol-induced neuroinflammation in vivo and in vitro: Involvement of TLR2-MyD88-NF-κB pathway.
Topics: Animals; Central Nervous System Diseases; Ethanol; Memory Disorders; Myeloid Differentiation Factor 88; Neuroprotective Agents; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Toll-Like Receptor 2 | 2018 |
Effects of resveratrol pretreatment on endoplasmic reticulum stress and cognitive function after surgery in aged mice.
Topics: Animals; Cognition; Cognitive Dysfunction; Endoplasmic Reticulum Stress; Hippocampus; Inflammation Mediators; Locomotion; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Neurons; NF-kappa B; Postoperative Complications; Preoperative Care; Resveratrol; Sirtuin 1 | 2018 |
Resveratrol improves cognition and decreases amyloid plaque formation in Tg6799 mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Amyloid; Presenilin-1; Resveratrol | 2019 |
Behavioral and molecular effects of intrahippocampal infusion of auraptene, resveratrol, and curcumin on H-89-induced deficits on spatial memory acquisition and retention in Morris water maze.
Topics: Animals; Coumarins; Curcumin; Cyclic AMP Response Element-Binding Protein; Hippocampus; Infusions, Parenteral; Isoquinolines; Male; Memory; Memory Disorders; Neuroprotective Agents; Rats, Wistar; Resveratrol; Sulfonamides | 2019 |
Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Disease Models, Animal; Male; Memory Disorders; Memory, Short-Term; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid; Presenilin-1; Recognition, Psychology; Resveratrol; Stilbenes | 2014 |
Resveratrol exerts anti-inflammatory and neuroprotective effects to prevent memory deficits in rats exposed to chronic unpredictable mild stress.
Topics: Amygdala; Animals; Anti-Inflammatory Agents; Brain-Derived Neurotrophic Factor; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Emotions; Hippocampus; Injections, Intraperitoneal; Interleukin-1beta; Male; Memory Disorders; Neuroprotective Agents; Proto-Oncogene Proteins c-fos; Rats, Wistar; Resveratrol; Spatial Learning; Spatial Memory; Stilbenes; Stress, Psychological; Tumor Necrosis Factor-alpha; Uncertainty | 2015 |
Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation.
Topics: Aging; Animals; Astrocytes; CD11b Antigen; Cells, Cultured; Doublecortin Domain Proteins; Glial Fibrillary Acidic Protein; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Microtubule-Associated Proteins; Microvessels; Mood Disorders; Neurogenesis; Neuroglia; Neuropeptides; Rats; Rats, Inbred F344; Resveratrol; Stilbenes | 2015 |
Resveratrol improved the spatial learning and memory in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization.
Topics: Animals; Antioxidants; Asymptomatic Diseases; Behavior, Animal; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hippocampus; Hormone Replacement Therapy; Hypothyroidism; Learning Disabilities; Male; Maze Learning; Memory Disorders; Nerve Tissue Proteins; Neurons; Nootropic Agents; Random Allocation; Rats, Sprague-Dawley; Resveratrol; Spatial Learning; Stilbenes; Synaptotagmin I; Thyroxine | 2015 |
Resveratrol Reverses the Synaptic Plasticity Deficits in a Chronic Cerebral Hypoperfusion Rat Model.
Topics: Animals; Carotid Stenosis; Cerebrovascular Circulation; Chronic Disease; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dementia, Vascular; Dendritic Spines; Dentate Gyrus; Enzyme Activation; Hypoxia-Ischemia, Brain; Learning Disabilities; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Nerve Tissue Proteins; Neuroprotective Agents; Random Allocation; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2016 |
Obesity Weighs down Memory through a Mechanism Involving the Neuroepigenetic Dysregulation of Sirt1.
Topics: Animals; Antioxidants; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; DNA Methylation; Excitatory Postsynaptic Potentials; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Insulin; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Obesity; Prosencephalon; Recognition, Psychology; Resveratrol; Sirtuin 1; Spatial Memory; Stilbenes; Time Factors | 2016 |
Protective effect of resveratrol against chronic intermittent hypoxia-induced spatial memory deficits, hippocampal oxidative DNA damage and increased p47Phox NADPH oxidase expression in young rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Deoxyguanosine; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Glutamic Acid; Glutathione; Glutathione Reductase; Hemoglobins; Hippocampus; Hypoxia; Male; Maze Learning; Memory Disorders; NADPH Oxidases; Neuroprotective Agents; Rats; Rats, Wistar; Reaction Time; Resveratrol; Stilbenes; Thiobarbituric Acid Reactive Substances | 2016 |
The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Male; Memory Disorders; Mice; Mice, Inbred ICR; Peptide Fragments; Phosphodiesterase 4 Inhibitors; Resveratrol; Signal Transduction; Stilbenes | 2016 |
Resveratrol ameliorates spatial learning memory impairment induced by Aβ
Topics: Amyloid beta-Peptides; Animals; Blotting, Western; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Hippocampus; Learning Disabilities; Long-Term Potentiation; Male; Memory Disorders; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Phosphorylation; Random Allocation; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Spatial Learning; Spatial Memory; Stilbenes; Time Factors | 2017 |
Resveratrol Attenuates Subacute Systemic Inflammation-Induced Spatial Memory Impairment via Inhibition of Astrocyte Activation and Enhancement of Synaptophysin Expression in the Hippocampus.
Topics: Animals; Astrocytes; Blotting, Western; Glial Fibrillary Acidic Protein; Hippocampus; Hyperalgesia; Immunohistochemistry; Inflammation; Lipopolysaccharides; Male; Maze Learning; Memory Disorders; Mice, Inbred ICR; Microglia; Models, Biological; Resveratrol; Sirtuin 1; Spatial Memory; Stilbenes; Synaptophysin | 2017 |
Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats.
Topics: Acetylcholinesterase; Animals; Avoidance Learning; Behavior, Animal; Blood Glucose; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Memory; Memory Disorders; Random Allocation; Rats; Resveratrol; Stilbenes; Streptozocin | 2009 |
Beneficial effects of resveratrol on scopolamine but not mecamylamine induced memory impairment in the passive avoidance and Morris water maze tests in rats.
Topics: Animals; Avoidance Learning; Male; Maze Learning; Mecamylamine; Memory Disorders; Rats; Rats, Wistar; Reaction Time; Resveratrol; Scopolamine; Stilbenes | 2011 |
Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diet, High-Fat; Fatty Liver; Glucose Tolerance Test; Inflammation; Insulin Resistance; Male; Maze Learning; Memory Disorders; Mice; Obesity; Resveratrol; Stilbenes | 2012 |
Long-term resveratrol consumption protects ovariectomized rats chronically treated with D-galactose from developing memory decline without effects on the uterus.
Topics: Animals; Antioxidants; Body Weight; Eating; Emotions; Estradiol; Female; Galactose; Glutathione Peroxidase; Hippocampus; Maze Learning; Memory; Memory Disorders; Motor Activity; Neurons; Ovariectomy; Oxidation-Reduction; Protein Carbonylation; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Uterus | 2012 |
Effect of resveratrol on scopolamine-induced cognitive impairment in mice.
Topics: Animals; Avoidance Learning; Behavior, Animal; Cognition Disorders; Injections, Intraperitoneal; Maze Learning; Memory Disorders; Mice; Motor Activity; Muscarinic Antagonists; Neuroprotective Agents; Reaction Time; Resveratrol; Scopolamine; Stilbenes; Treatment Outcome | 2012 |
Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules.
Topics: Amyloid beta-Peptides; Animals; Astrocytes; beta Catenin; Cytoprotection; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Injections, Intraventricular; JNK Mitogen-Activated Protein Kinases; Lipids; Male; Memory Disorders; Microglia; Nanocapsules; Neuroprotective Agents; Protein Stability; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Stilbenes; Synapses; Tissue Distribution | 2013 |
Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Antioxidants; Behavior, Animal; Brain; Cognition Disorders; Colchicine; Glutathione; Injections, Intraventricular; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Memory Disorders; Neuroprotective Agents; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Space Perception; Stilbenes; Tubulin Modulators | 2007 |
Neuroprotective effects of resveratrol against traumatic brain injury in immature rats.
Topics: Animals; Animals, Newborn; Antioxidants; Anxiety; Brain Injuries; Cell Death; Cognition Disorders; Hippocampus; Injections, Intraperitoneal; Memory; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes; Treatment Outcome | 2007 |